Ras regulation of cyclin-dependent immunoprecipitation kinase assays (Q34278559)

1 August 2017

1 reference

title

Ras regulation of cyclin-dependent immunoprecipitation kinase assays (English)

1 reference

1 August 2017

Zafonte BT

1 reference

1 August 2017

Amanatullah DF

1 reference

1 August 2017

Sage D

1 reference

1 August 2017

Augenlicht LH

1 reference

1 August 2017

Pestell RG

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

1 August 2017

published in

Methods in Enzymology

1 reference

1 August 2017

volume

333

1 reference

1 August 2017

page(s)

127-138

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

1 August 2017

1 reference

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Cyclin D and oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Different roles for cyclins D1 and E in regulation of the G1-to-S transition

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Cyclin E-induced S phase without activation of the pRb/E2F pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

D-type cyclin-dependent kinase activity in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Tumor surveillance via the ARF-p53 pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

New functional activities for the p21 family of CDK inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Cdc25 cell-cycle phosphatase as a target of c-myc

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

CDC25 phosphatases as potential human oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Ras versus cyclin-dependent kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Cell cycle targets of Ras/Raf signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Role of the INK4a locus in tumor suppression and cell mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1).

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Functional domains in cyclin D1: pRb-kinase activity is not essential for transformation.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

CDK-independent activation of estrogen receptor by cyclin D1

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Mechanisms of cyclin-dependent kinase inactivation by progestins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

Identification of G1 kinase activity for cdk6, a novel cyclin D partner

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2801%2933051-3

7 January 2021

10.1016/S0076-6879(01)33051-3

Identifiers

DOI

1 reference

1 August 2017

1 reference